Question 1

The benefits of enoxaparin over heparin include that it:

Accepted Answer

A)  is less likely to cause thrombocytopaenia and is more effective in reducing mortality and myocardial infarction in unstable angina. 
B)  has a longer half-life requiring less frequent monitoring and is safer in pregnancy. 
C)  A and B. 
D)  neither A nor B. 
A)  is less likely to cause thrombocytopaenia and is more effective in reducing mortality and myocardial infarction in unstable angina. 
B)  has a longer half-life requiring less frequent monitoring and is safer in pregnancy. 
C)  A and B. 
D)  neither A nor B. C

Question 2

The antiplatelet agent abciximab is structurally related to

Accepted Answer

A)  calcium channel blockers. 
B)  a bacterial enzyme. 
C)  the ADP receptor. 
D)  a vaccine. 
A)  calcium channel blockers. 
B)  a bacterial enzyme. 
C)  the ADP receptor. 
D)  a vaccine. D

Question 3

To reverse anticoagulation caused by heparin,________ is usually administered.

Accepted Answer

A)  prostaglandin 
B)  warfarin 
C)  tranexamic acid 
D)  protamine 
A)  prostaglandin 
B)  warfarin 
C)  tranexamic acid 
D)  protamine D

Question 4

When using aspirin as an antiplatelet agent,how many days before any planned surgery or dental procedures should it be stopped?

Accepted Answer

A)  2 days 
B)  7 days 
C)  14 days 
D)  21 days 
A)  2 days 
B)  7 days 
C)  14 days 
D)  21 days

Question 5

When a tissue is injured,the process of clotting begins.Which statement is true about that process?

Accepted Answer

A) Thrombin forms prothrombin. 
B) The process is dependent on intrinsic and extrinsic pathways. 
C) Potassium ions play a crucial role in clotting. 
D) Fibrin forms fibrinogen. 
A) Thrombin forms prothrombin. 
B) The process is dependent on intrinsic and extrinsic pathways. 
C) Potassium ions play a crucial role in clotting. 
D) Fibrin forms fibrinogen.

Question 6

After about ________ hours of oral anticoagulant therapy with warfarin,the heparin can be withdrawn,as it takes this amount of time for the oral anticoagulant to exert its effect.

Accepted Answer

A)  2 
B)  12 
C)  24 
D)  48 
A)  2 
B)  12 
C)  24 
D)  48

Question 7

The benefit of ________ for the treatment of thrombosis is that it is clot-specific,thereby reducing the risk of generalised haemorrhage.

Accepted Answer

A)  warfarin 
B)  urokinase 
C)  streptokinase 
D)  tissue plasminogen activator 
A)  warfarin 
B)  urokinase 
C)  streptokinase 
D)  tissue plasminogen activator

Question 8

What is the haemostatic agent used in colposcopy procedures?

Accepted Answer

A) Monsel's solution 
B) Calcium alginate 
C) Eltrombopag 
D) Octocog alfa 
A) Monsel's solution 
B) Calcium alginate 
C) Eltrombopag 
D) Octocog alfa

Question 9

Which one of the following is an endogenous substance known to inhibit coagulation?

Accepted Answer

A)  cAMP 
B)  Thromboxane A2 
C)  ADP 
D)  von Willebrand factor 
A)  cAMP 
B)  Thromboxane A2 
C)  ADP 
D)  von Willebrand factor

Exam 47: Antithrombotic, Fibrinolytic and Haemostatic Agents

The benefits of enoxaparin over heparin include that it:

The antiplatelet agent abciximab is structurally related to

To reverse anticoagulation caused by heparin,________ is usually administered.

When using aspirin as an antiplatelet agent,how many days before any planned surgery or dental procedures should it be stopped?

When a tissue is injured,the process of clotting begins.Which statement is true about that process?

After about ________ hours of oral anticoagulant therapy with warfarin,the heparin can be withdrawn,as it takes this amount of time for the oral anticoagulant to exert its effect.

The benefit of ________ for the treatment of thrombosis is that it is clot-specific,thereby reducing the risk of generalised haemorrhage.

What is the haemostatic agent used in colposcopy procedures?

Which one of the following is an endogenous substance known to inhibit coagulation?

Sociocultural Aspects

Health Professionals and the Law

Ethical Issues

the Roles and Responsibilities of Health Professionals in Medicine Adherence, Education and Advocacy

the Roles and Responsibilities of Health Professionals in Medicine Management

Medicine Formulations, Storage and Routes of Administration

the Clinical Decision-making Process

Medicine Administration Strategies and Documentation

Medication Errors

Management of Common Adverse Drug Reactions

Risk Communication: Balancing the Benefits and Risks of Drug Treatment

Drug Nomenclature

Pharmacokinetics: Absorption and Distribution

Pharmacokinetics Metabolism and Excretion

Drug Interactions

Pharmacodynamics

Drug Development, Evaluation and Safety

Genetic Considerations in Pharmacology

Pharmacokinetic Factors That Modify Drug Action

Paediatric and Geriatric Pharmacology

Poisoning and Envenomation

the Management of Acute Clinical Overdose

Contemporary Drugs of Abuse

Drug Abuse in Sport

General Aspects of Neuropharmacology

Adrenergic Pharmacology

Cholinergic Pharmacology

An Introduction to Chemical Mediators

Histamine and Antihistamines

Prostaglandins and Serotonin

Nitric Oxide and the Endothelins

General concepts of Psychopharmacology

Antipsychotics

Anxiolytics and Hypnotics

Antidepressants and Mood Stabilisers

Medicines Used in Neurodegenerative Disorders

Antiseizure Agents and Muscle Relaxants

Central Nervous System Stimulants

Opioid Analgesics

Anti-inflammatory, Antipyretic and Non-opioid Analgesic Agents

Medicines Used to Treat Migraine

General Anaesthesia

Local Anesthesia

Medicines Used to Lower Blood Lipids

Antihypertensive Agents

Medicines Used to Promote Tissue Perfusion

Diuretics and Other Renal Medicines

Topic: Medicines Used to Treat Heart Failure

Medicines Used to Treat Cardiac Dysrhythmia

Fluid and Potassium Imbalances

Antianaemic Agents

Medicines Used to Maintain Gas Exchange

Medicines for Upper Respiratory Tract Conditions

Upper Gastrointestinal Tract Medicines

Lower Castrointestinal Tract Medicines

Antiemetic Agents

Enteral and Parenteral Nutrition

Medicines and the Pituitary Gland

Medicines and the Thyroid

Medicines and the Pancreas

Medicines Affecting the Adrenal Cortex

Medicines and the Gonads

Medicines and Bone Metabolism

Hyperuricaemia and Gout

Obesity and Its Treatment

Introduction to Chemotherapy

Sulfonamides and Trimethoprim

Antibacterial Agents

Antituberculotic and Antileprotic Agents

Antiseptics and Disinfectants